Nitric oxide scavengers in the treatment of shock associated with systemic inflammatory response syndrome

Bibliography

• PARRILO JE: Septic shock in humans: advances in theunderstanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann. Intern. Med. (1990) 113:227–242.
   PubMedGoogle Scholar
• HEYLAND DK, COOK DF: Boosting oxygen delivery wasnot effective in critically ill patients. Ann. Intern. Med. (1994) 121:63.
   Google Scholar
• SHOEMAKER WC, APPEL PL, KRAM HB et al.: Prospectivetrial of supranormal values of survivors as therapeutic goals in high-risk surgical patients. Chest (1988) 94:1176–1186.
   PubMed Web of Science ®Google Scholar
• BOYD 0, GROUNDS RM, BENNETT ED: A randomized clinical trial of the effect of deliberate perioperative increase of oxygen delivery on mortality in high-risk surgical patients. JAMA (1993) 270:2699–2707.
   PubMed Web of Science ®Google Scholar
• HAYES MA, TIMMINS AC, YAU EHS et al: Elevation of systemic oxygen delivery in the treatment of critically ill patients. New. Engl. J. Med. (1994) 330:1717–1722.
   PubMed Web of Science ®Google Scholar
• AMERICAN COLLEGE OF CHEST PHYSICIANS/SOCIETYOF CRITICAL CARE MEDICINE CONSENSUS CONFER-ENCE: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit. Care Med. (1992) 20:864–874.
   PubMed Web of Science ®Google Scholar
• RANGEL-FRAUSTO MS, PITTET D, COSTIGAN M et al.: Thenatural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA (1995) 273:117–123.
   Google Scholar
• PARRATT JR: Alterations in vascular reactivity in sepsis and endotoxemia. In: Update in Intensive Care and Emergency Medicine 1989. Vincent JL (Ed.), Springer-Verlag, Brussels, Belgium (1990299–308.
   Google Scholar
• GROENVELD ABJ, NAUTA JJP, THUS LG: Peripheral vascular resistance in septic shock: its relation to outcome. Intensive Care Med. (1988) 14:141–147.
   PubMedGoogle Scholar
• PARRILLO JE: Cardiovascular dysfunction in septic shock: new insights into a deadly disease. Int. J. Cardiol (1985) 7:314–321.
   PubMedGoogle Scholar
• PARRILLO JE: Cardiovascular dysfunction in humans with septic shock. In: Update in Intensive Care and Emergency Medicine 1986, Vincent JL (Ed.), Springer-Verlag, Brussels, Belgium (1987):265–274.
   Google Scholar
• SIEGEL JH, CERRA FB, COLEMAN B et al.: Physiological and metabolic correlations in human sepsis. Surgery (1979) 86:163–193.
   PubMed Web of Science ®Google Scholar
• PARKER MM, SHELHAMER JH, NATANSON C et al. : Serial cardiovascular variables in survivors and nonsurvi-vors of human septic shock: heart rate as an early predictor of prognosis. Grit. Care Med. (1987) 15:923–929.
   PubMed Web of Science ®Google Scholar
• PILZ G, WERDAN K: Cardiovascular parameters andscoring systems in the evaluation of response to therapy in sepsis and septic shock. Infection (1990) 18:253–262.
   PubMedGoogle Scholar
• JONES SB, ROMANO FD: Myocardial beta adrenergic receptor coupling to adenylate cyclase during developing septic shock. Circ. Shock (1990) 30:51–61.
   PubMedGoogle Scholar
• RYDING J, HESLET L, HARTVIG T et al: Reversal of 'refra-ctory septic shock' by infusion of amrinone and angiotension II in an anthracycline-treated patient. Chest (1995) 107:201–203.
   PubMedGoogle Scholar
• UNVERVERTH DV, BLANFORD M, KATES RE et al: Tolerance to dobutamine after a 72 hour continuous infusion. Am. J. Med. (1980) 69:262–266.
   PubMedGoogle Scholar
• SCHALLER MD, WAEBER B, NUSSBERGER J et al.: Angiotensin II, vasopressin, and sympathetic activity in conscious rats with endotoxemia. Am. J. Physic)]. (1985) 249:H1086–H1092.
   Google Scholar
• MCCAIG DJ, PARRATT JR: Reduced myocardial response to calcium during endotoxin shock in the cat. Circ. Shock (1980) 7:23–30.
   PubMedGoogle Scholar
• ARCHER SL, HUANG JMC, HAMPL V et al.: Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase. Proc. Nati Acad. ScL USA (1994) 91:7583–7587.
   PubMedGoogle Scholar
• BROWN RB, RICE BH, SZAKACS JE: Intestinal bleeding and perforation complicating treatment with vasocon-strictors. Ann. Surg. (1959) 150:790–798.
   PubMedGoogle Scholar
• CHAMPAGNAT J, DENAVIT-SAUBIE M, HENRY JL et al.: Catecholaminergic depressant effects on bulbar respiratory mechanisms. Brain Res. (1979) 160:57–68.
   PubMed Web of Science ®Google Scholar
• CUNNINGHAM DJ, HEY EN, PATRICK JM et al.: The effect of noradrenaline infusion on the relation between pulmonary ventilation and the alveolar Po2 and Pco2 in man. Ann. NY Acad. Sci.(1963) 109:756–771.
   PubMed Web of Science ®Google Scholar
• FELLOWS IW, BENNETT T, MACDONALD IA: The effect of adrenaline upon cardiovascular and metabolic functions in man. Clin. ScL (1985) 69:215–222.
   PubMedGoogle Scholar
• GILBERT EM, HAUPT MT, MANDANAS RY et al.: The effectof fluid loading, blood transfusion, and catecholamine © Ashley Publications Ltd. All rights reserved. infusion on oxygen delivery and consumption in patients with sepsis. Am. Rev. Respir. Dis. (1986) 134:873–878.
   Google Scholar
• GOLBRANSON FL, LURIE L, VANCE RM et al.: Multiple extremity amputations in hypotensive patients treated with dopamine. JAMA (1980) 243:1145–1146.
   PubMed Web of Science ®Google Scholar
• GREEN CJ, FRAZER RS, UNDERHILL S et al.: Metabolic effects of dobutamine in normal man. Clin. Sci. (1992) 82:77–83.
   Google Scholar
• HAMBURG S, HENDLER R, SHERWIN RS: Influence of small increments of epinephrine on glucose tolerance in normal humans. Ann. Intern. Med. (1980) 93:566–568.
   PubMed Web of Science ®Google Scholar
• HEYLAND DK, COOK DJ, KING D et al.: Maximizingoxygen delivery in critically ill patients: a method-ologic appraisal of the evidence. Grit. Care Med. (1996) 24:517–524.
   PubMed Web of Science ®Google Scholar
• MCNEIL JR, STARK RD, GREENWAY CV: Intestinalvasoconstriction after hemorrhage: roles of vasopressin and angiotensin. Am. J. Physiol. (1970) 219:1342–1347.
   PubMedGoogle Scholar
• RIZZA RA, CRYER PE, HATMOND MW et al.: Adrenergic mechanisms of catecholamine action on glucose homeostasis in man. Metabolism (1980) 29:1155–1163.
   PubMedGoogle Scholar
• ROSCH PJ: Gastrointestinal bleeding in pheochromo-cytoma and following the administration of norepi-nephrine (artereno0. AMA Arch. Intern. Med. (1958) 13/175-17/179.
   Google Scholar
• SACCA L, MORRONE G, CICALA M et al.: Influence of epinephrine, norepinephrine, and isoproterenol on glucose homeostasis in normal man. J. Clin. Endocrinol Metab. (1980) 50:680–684.
   PubMed Web of Science ®Google Scholar
• SHERWIN RS, SHAMOON H, HENDLER R et al: Epineph-rine and the regulation of glucose metabolism: effect of diabetes and hormonal interactions. Metabolism (1980) 29:1146–1154.
   PubMedGoogle Scholar
• SVEDMYR N: Studies on the mechanism for the calori-genic effect of adrenaline in man. Acta. Physiol. Scand. (1966) 68:84–95.
   Google Scholar
• VAN DEN BERGHE G, DE ZEGHER F: Anterior pituitary function during critical illness and dopamine treatment. Crit. Care Med. (1996) 24:1580–1590.
   PubMedGoogle Scholar
• ZERN RT, FOSTER LB, BLALOCK JA et al: Characteristics of the dopaminergic and noradrenergic systems of the pancreatic islets. Diabetes (1979) 28:185–189.
   PubMedGoogle Scholar
• TIGHE D, MOSS R, BENNETT D: Cell surface adrenergic receptor stimulation modifies the endothelial response to SIRS. New Horizons (1996) 4:426–442.
   PubMedGoogle Scholar
• VAN DER POLL T, COYLE SM, BARBOSA K et al: Epineph-rine inhibits tumor necrosis factor-a and potentiates interleukin 10 production during human endotoxemia. j Clin. Inves.t (1996) 97:713–719.
   PubMedGoogle Scholar
• ODDIS CV, SIMMONS RL, HATTLER BC et al: Proteinkinase A activation is required for IL-1-induced nitric oxide production by cardiac myocytes. Am. J. Physiol. (1996) 271:C429–C434.
   Google Scholar
• ODDIS CV, SIMMONS RL, HATTLER BG et al: cAMP enhances inducible nitric oxide synthase mRNA stability in cardiac myocytes. Am. J. Physiol. (1995) 269:H2044–H2050.
   Google Scholar
• SIBBALD WJ, VINCENT J-L: Round table conference onclinical trials for the treatment of sepsis. Grit. Care. Med. (1995) 23:394–399.
   PubMed Web of Science ®Google Scholar
• THIRD EUROPEAN CONSENSUS CONFERENCE IN INTENSIVE CARE MEDICINE: Tissue hypoxia: how to detect, how to correct, how to prevent. Am. J. Respir. Grit. Care. Med. (1996) 154:1573–1578.
   PubMedGoogle Scholar
• TASK FORCE OF THE AMERICAN COLLEGE OF CRITICALCARE MEDICINE, SOCIETY OF CRITICAL CARE MEDICINE: Practice parameters for hemodynamic support of sepsis in adult patients in sepsis. Grit. Care Med. (1999) 27:639–660.
   PubMedGoogle Scholar
• AKAIKE T, YOSHIDA M, MIYAMOTO Y et al.: Antagonisticaction of imidazolineoxyl N-oxides against endothelium-derived relaxing factor/NO through a radical reaction. Biochemistry (1993) 32:827–832.
   PubMed Web of Science ®Google Scholar
• GREENBERG SS, XIE J, ZATARAIN JM, KAPUSTA DR, MILLER MJ: Hydroxocobalamin (vitamin B12a) prevents and reverses endotoxin-induced hypoten-sion and mortality in rodents: role of nitric oxide. J. Pharmacol. Exp. Ther. (1995) 273:257–265.
   PubMed Web of Science ®Google Scholar
• LAI CS, KOMAROV AM: Spin trapping of nitric oxide produced in vivo in septic-shock mice. FEBS. Letts. (1994) 345:120–124.
   PubMed Web of Science ®Google Scholar
• FRICKER SP, SLADE E, POWELL NA et al: Rutheniumcomplexes as nitric oxide scavengers: a potential therapeutic approach to nitric oxide-mediated disease. Br. J. Pharmacol. (1997) 122:1441–1449.
   PubMed Web of Science ®Google Scholar
• IWASHITA Y: Hemoglobin conjugated with polyoxyethylene. Artificial Red Cells, Tsuchida E (Ed.), John Wiley & Sons Ltd., (1995):151–176.
   Google Scholar
• FRICKER S: Nitrogen monoxide-related disease andnitrogen monoxide scavengers as potential drugs. In: Metal Ions in Biological Systems, Sigel A, Sigel H (Eds.), Marcel Dekker, New York, USA (1999):665–721.
   Google Scholar
• SZABO C: Alterations in nitric oxide production invarious forms of circulatory shock. NewHorizons (1995) 3:2–32.
   Google Scholar
• KILBOURN RG, TRABER DL, SZABO C: Nitric oxide and shock. Disease Month (1997) 43:287–348.
   Google Scholar
• KILBOURN RG, JUBRAN A, GROSS SS et al.: Reversal of endotoxin-mediated shock by NG-methyl-L-arginine, an inhibitor of nitric oxide synthesis. Biochem. Biophys. Res. Comm (1990) 172:1132–1138.
   PubMed Web of Science ®Google Scholar
• FINKEL MS, ODDIS CV, JACOB TD et al.: Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science (1992) 257:387–398.
   PubMed Web of Science ®Google Scholar
• YOKOKAWA K, MANKUS R, SAKLAYEN MG et al: Increased nitric oxide production in patients with hypotension during hemodialysis. Ann. Intern. Med. (1995) 123:35–37.
   PubMed Web of Science ®Google Scholar
• PARRILLO JE: Pathogenic mechanisms of septic shock. New. Engl. J. Merl. (1993) 328:1471–1477.
   PubMed Web of Science ®Google Scholar
• BRADY AJB, POOLE-WILSON PA, HARDING SE, WARREN, JB: Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia. Am. J. Physiol (1992) 263:H1963–H1966.
   Google Scholar
• HIBBS JB, JR, VAVRIN Z, TAINTOR RR: L-arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. J. Immun. (1987) 138:550–565.
   PubMed Web of Science ®Google Scholar
• MULLIGAN MS, HEVEL JM, MARLETTA MA, WARD PA: Tissue injury caused by deposition of immune complexes is L-arginine dependent. Proc. Natl. Acad. Sci. USA (1991) 88:6338–6342.
   PubMed Web of Science ®Google Scholar
• VAN DERVORT AL, YAN L, MADARA PJ et al.: Nitric oxide regulates endotoxin-induced TNF-a production by human neutrophils. j Immun. (1994) 152:4102–4109.
   PubMed Web of Science ®Google Scholar
• WINSLOW RM: Hemoglobin-based red cell substitutes. Johns Hopkins Press, Baltimore, USA (1992):182–184.
   Google Scholar
• NAKAI K, MATSUDA N, AMANO M et al.: Acellular andcellular hemoglobin solutions as vasoconstrictive factor. Artif Cells Blood Substit. Immobil. Biotechnol. (1994) 22:559–564.
   PubMed Web of Science ®Google Scholar
• RIOUX F, PETITCLERC E, AUDET R et al.: Recombinanthuman hemoglobin inhibits both constitutive and cytokine-induced nitric oxide-mediated relaxation of rabbit isolated aortic rings. J. Cardiovasc. Pharm. (1994) 24:229–237.
   PubMedGoogle Scholar
• KIDA Y, MAEDA M, IWATA S et al.: Effects of pyridox-alated hemoglobin polyoxyethylene conjugate and other hemoglobin-related substances on arterial blood pressure in anesthetized and conscious rats. Artif Organs (1995) 19:117–128.
   PubMedGoogle Scholar
• KILBOURN RG, JOLY G, CASHON B et al.: Cell-free hemoglobin reverses the endotoxin-mediated hypore-sponsivity of rat aortic rings to a-adrenergic agents. Biochem. Biophys. Res. Comm (1994) 199:155–162.
   PubMed Web of Science ®Google Scholar
• CASSOLY R, GIBSON QH: Conformation, co-operativity and ligand binding in human hemoglobin. J. Mol. Bio. (1975) 91:301–313.
   PubMed Web of Science ®Google Scholar
• MOORE EG, GIBSON QH: Cooperativity in the dissocia-tion of nitric oxide from hemoglobin. J. Biol. Chem. (1976) 9:2788–2794.
   Google Scholar
• DOYLE MP, HOEKSTRA JW: Oxidation of nitrogen oxides by bound dioxygen in hemoproteins. J. Inorg. Biochem. (1981) 14:351–358.
   PubMed Web of Science ®Google Scholar
• GIBSON QH, ROUGHTON FJW: The kinetics and equilibria of the reactions of nitric oxide with sheep hemoglobin. J. Physiol. (1957) 136:507–526.
   PubMedGoogle Scholar
• SHARMA VS, RANNEY HM: The dissociation of NO fromnitrosylhemoglobin. J. Biol. Chem. (1978) 18:6467–6472.
   Google Scholar
• SHARMA VS, TRAYLOR TG, GARDINER R, MIZUKAMI H:Reaction of nitric oxide with heme proteins and model compounds of hemoglobin. Biochemistry (1987) 26:3837–3843.
   PubMed Web of Science ®Google Scholar
• ADDISON AW, STEPHANOS JJ: Nitrosyliron(III)hemoglobin: autoreduction and spectroscopy. Biochemistry (1986) 25:4104–4113.
   PubMed Web of Science ®Google Scholar
• ALAYASH Al, FRATANTONI JC, BONAVENTURA C et al.:Nitric oxide binding to human ferrihemoglobins cross- linked between either a or 6 subunits. Arch. Biochem. Biophys. (1993) 303:332–338.
   PubMed Web of Science ®Google Scholar
• ALAYASH Al, RYAN AB, FRATANTONI JC et al.: Redoxreactivity of modified hemoglobins. Artif Cells Blood Substit. Immobil Biotechnol. (1994) 22:373–386.
   PubMed Web of Science ®Google Scholar
• LANCASTER JR, JR: Simulation of the diffusion andreaction of endogenously produced nitric oxide. Proc. Nail Acad. Sci. USA (1994) 91:8137–8141.
   PubMed Web of Science ®Google Scholar
• WANG Q, JACOBS J, DELEO J et al.: Nitric oxidehemoglobin in mice and rats in endotoxic shock. Life Sci. (1991) 49:PL–55–60.
   Google Scholar
• KOSAKA H, WATANABE M, YOSHIHARA H et al.: Detection of nitric oxide production in lipopolysaccharide-treated rats by ESR using carbon monoxide hemoglobin. Biochem. Biophys. Res. Comm. (1992) 184:1119–1124.
   PubMed Web of Science ®Google Scholar
• WESTENBERGER U, THANNER S, RUF HH et al.: Formation of free radicals and nitric oxide derivative of hemoglobin in rats during shock syndrome. Free Rad. Res. Comm. (1990) 11:167–178.
   PubMed Web of Science ®Google Scholar
• GOMEZ-JIMENEZ J, SALGADO A, MOURELLE M et al.: L-arginine: nitric oxide pathway in endotoxemia and human septic shock. Crit. Care Med. (1995) 23:253–258.
   PubMed Web of Science ®Google Scholar
• OCHOA JB, UDEKWU AO, BILLIAR TR et al.: Nitrogen oxide levels in patients after trauma and during sepsis. Ann. Surg. (1991) 214:621–626.
   PubMed Web of Science ®Google Scholar
• KILBOURN RG, GRIFFITH OW: Overproduction of nitric oxide in cytokine-mediated and septic shock. J. Natl. Can. Inst. (1992) 84:827–833.
   PubMed Web of Science ®Google Scholar
• BONE HG, SCHENARTS PJ, BOOKE M et al.: Oxalatedpyridoxalated hemoglobin polyoxyethylene conjugate normalizes the hyperdynamic circulation in septic sheep. Crit. Care Merl. (1997) 25:1010–1018.
   PubMed Web of Science ®Google Scholar
• FISCHER SR, BONE HG, TRABER DL: Effects ofhemoglobin in sepsis. In: The Yearbook of Intensive Care and Emergency Medicine. Vincent JL (Ed.), Springer-Verlag, Brussels, Belgium (1997):424–441.
   Google Scholar
• FISCHER SR, BONE HG, POWELL WC et al.: Pyridoxalatedhemoglobin polyoxyethylene conjugate (PHP) does not restore hypoxic pulmonary vasoconstriction in ovine sepsis. Crit. Care Med. (1997) 25:1551–1559.
   PubMedGoogle Scholar
• BONE HG, WAURICK R, VAN AKEN H et al: Comparisonof the haemodynamic effects of nitric oxide synthase inhibition and nitric oxide scavenging in endotox- aemic sheep. Intensive Care Med. (1998) 24:48–54.
   PubMed Web of Science ®Google Scholar
• BONE HG, SCHENARTS PJ, FISCHER SR et al.: Pyridox-alated hemoglobin polyoxyethylene conjugate reverses hyperdynamic circulation in septic sheep. J. Appl. Physic)]. (1998) 84:1991–1998.
   PubMed Web of Science ®Google Scholar
• BONE HG, FISCHER SR, SCHENARTS PJ eta].: Continuous infusion of pyridoxalated hemoglobin polyoxyeth-ylene conjugate in hyperdynamic sheep. Shock (1998) 10:69–76.
   Google Scholar
• METRANGOLO L, FIORILLO M, FRIEDMAN G eta].: Early hemodynamic course of septic shock. Crit. Care Med. (1995) 23:1971–1975
   Google Scholar
• RUOKONEN E, TAKALA J, KARI A et al.: Septic shock and multiple organ failure. Crit. Care Med. (1991) 19:1146–1151.
   PubMed Web of Science ®Google Scholar
• GROENEVELD ABJ, BRONSVELD W, THUS LG: Hemody-namic determinants of mortality in human septic shock. Surgery (1986) 99:140–153.
   PubMedGoogle Scholar
• EXECUTIVE SUMMARY OF AN AMERICAN COLLEGE OFCHEST PHYSICIANS, NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASE, AND NATIONAL HEART, LUNG, AND BLOOD INSTITUTE WORKSHOP: From the bench to the bedside: the future of sepsis research. Chest (1997) 111:744–53.
   PubMedGoogle Scholar
• FISCHER SR, BONE HG, SCHENARTS PJ et al.: Loss of hypoxic pulmonary vasoconstriction in ovine sepsis is restored by L-NMMA. Anesthesiology (1996) 85:A559.
   Google Scholar
• GROVER R, LOPEZ A, LORENTE J et al.: Multi-center, randomized, placebo-controlled, double blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Crit. Care Med. (1999) 27\(Suppl. 1):A33.
   Google Scholar
• GROVER R, ZACCARDELLI D, COLICE G et al.: An open-label dose escalation study of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochlo-ride (546C88), in patients with septic shock. Crit. Care Med. (1999) 27:913–22.
   PubMed Web of Science ®Google Scholar
• COHEN RA, WEISBROD RM, GERICKE M et al.: Mechanism of nitric oxide-induced vasodilatation. Circ. Res. (1999) 84:210–219.
   PubMedGoogle Scholar
• IWASHITA YJ: Hemoglobin conjugated with polyoxyethylene. In: Artificial Red Cells: Tsuchida E (Ed.), John Wiley & Sons, New York, USA (1995):151–176.
   Google Scholar
• BENESCH R, BENESCH RE: Preparation and properties of haemoglobin modified with derivatives of pyridoxal. In: Methods in Enzymology, Colowick SP, Kaplan NO (Eds.), Academic Press, New York, USA (1981) 76:147–158.
   PubMedGoogle Scholar